Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock.
about
Vasopressin and methylene blue: alternate therapies in vasodilatory shock.The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patientsEffect of arterial oxygen tension during reperfusion on myocardial recovery in patients undergoing valvular heart surgery.Year in review 2009: Critical Care--shock.Review article: the pathophysiology and management of gastrointestinal symptoms during physical exercise, and the role of splanchnic blood flow.Nutrition assessment, care, and considerations of ventricular assist device patients.Provision of enteral nutrition during vasopressor therapy for hemodynamic instability: an evidence-based review.Terlipressin in brain-death donors.Tolerability and safety of enteral nutrition in critically ill patients receiving intravenous vasopressor therapy.Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.Early enteral nutrition in critically ill patients with hemodynamic instability: an evidence-based review and practical advice.Feeding the Postoperative Patient on Vasopressor Support: Feeding and Pressor Support.Colon Perfusion Patterns During Colorectal Resection Using Visible Light Spectroscopy.Terlipressin protects intestinal epithelial cells against oxygen-glucose deprivation/re-oxygenation injury via the phosphatidylinositol 3-kinase pathway.Consecutive daily measurements of luminal concentrations of lactate in the rectum in septic shock patientsVasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
P2860
Q33391378-8586C0A9-448B-477C-8545-8BC628452C86Q33682301-0A8ACD50-E1E1-42CF-B1D5-94B25800AC47Q33861534-A05B707D-B955-43BD-9E63-E65BD0945572Q37814495-C063A6A4-AC71-4AE4-9B1E-C05BB4C9F618Q37974260-06DEF9FB-2126-4226-A808-0C0344B64806Q38004439-7FF9374F-B2CC-4AF5-963F-CBC07DF56BB5Q38018019-1FC39A54-542E-4A2A-A52F-4334D94C2DBBQ38057364-8A80EFFD-1918-449E-BA3A-417DBECD9025Q38070052-25DA24CF-4404-42E5-BE53-BAFA43232B1FQ38107537-5C6BFE3A-180D-426B-A5B3-00CF3630C5A0Q38180683-FC1EF7E1-7F56-436D-A18F-7F54D8390588Q38679369-D77A7F26-56A1-4C9B-A474-7C380BB1DD90Q40119018-046D473E-08CE-445D-9FA0-1C3F460A0FF2Q41016993-1F59A84D-6963-436A-A546-EA9A28FAE1DBQ42619970-9089071C-F739-43A3-833D-442C97456BDCQ47604231-DAE13867-80EE-408F-BACC-5DD9CE3443DB
P2860
Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Vasopressin decreases intestin ...... atients in vasodilatory shock.
@ast
Vasopressin decreases intestin ...... atients in vasodilatory shock.
@en
type
label
Vasopressin decreases intestin ...... atients in vasodilatory shock.
@ast
Vasopressin decreases intestin ...... atients in vasodilatory shock.
@en
prefLabel
Vasopressin decreases intestin ...... atients in vasodilatory shock.
@ast
Vasopressin decreases intestin ...... atients in vasodilatory shock.
@en
P1476
Vasopressin decreases intestin ...... atients in vasodilatory shock.
@en
P2093
S-E Ricksten
P304
P356
10.1111/J.1399-6576.2008.01900.X
P407
P577
2009-02-23T00:00:00Z